HU0202523A2 - Dosages of anti-erbb2 antibodies and their use for treatment of cancer diseases - Google Patents

Dosages of anti-erbb2 antibodies and their use for treatment of cancer diseases Download PDF

Info

Publication number
HU0202523A2
HU0202523A2 HU0202523A HU0202523A HU0202523A2 HU 0202523 A2 HU0202523 A2 HU 0202523A2 HU 0202523 A HU0202523 A HU 0202523A HU 0202523 A HU0202523 A HU 0202523A HU 0202523 A2 HU0202523 A2 HU 0202523A2
Authority
HU
Hungary
Prior art keywords
dose
antibody
mg
kg
administering
Prior art date
Application number
HU0202523A
Other languages
Hungarian (hu)
Inventor
Baughman
Shak
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US15101899P priority Critical
Priority to US21382200P priority
Application filed by Genentech Inc filed Critical Genentech Inc
Priority to PCT/US2000/023391 priority patent/WO2001015730A1/en
Publication of HU0202523A2 publication Critical patent/HU0202523A2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26848246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU0202523(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links